Design Therapeutics (DSGN) EBITDA (2020)
Historic EBITDA for Design Therapeutics (DSGN) over the last 1 years, with Q4 2020 value amounting to -$3.9 million.
- Design Therapeutics' EBITDA changed N/A to -$3.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$8.3 million, marking a year-over-year change of. This contributed to the annual value of -$8.3 million for FY2020, which is N/A changed from last year.
- Latest data reveals that Design Therapeutics reported EBITDA of -$3.9 million as of Q4 2020.
- In the past 5 years, Design Therapeutics' EBITDA ranged from a high of -$623000.0 in Q1 2020 and a low of -$3.9 million during Q4 2020